News from mylan inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Apr 17, 2015, 15:54 ET

Elton John AIDS Foundation joins forces with the Mylan Relay for Hope to accelerate the fight against HIV/AIDS

TORONTO, April 17, 2015 /CNW/ - Mylan N.V. (Nasdaq: MYL) and the Canadian AIDS Society (CAS) are proud to announce that the Elton John AIDS...

Apr 17, 2015, 14:45 ET

Mylan Comments on Recent Media Speculation

Mylan N.V. (NASDAQ: MYL) today commented on recent media speculation. Mylan Executive Chairman Robert J. Coury commented, "We note that there has...

Apr 17, 2015, 12:55 ET
Mylan

Federal Circuit Upholds Mylan's U.S. Patents on Perforomist® Inhalation Solution; Decision Prevents Approval of Teva ANDA

Mylan N.V. (Nasdaq: MYL) today announced the United States Court of Appeals for the Federal Circuit upheld the validity and infringement of all...

Apr 13, 2015, 15:10 ET

Mylan Settles Patent Litigation Related to Viagra®

 Mylan N.V. (NASDAQ: MYL) today announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals Inc. ("Mylan") have entered into a...

Apr 13, 2015, 06:45 ET

Mylan Notifies Perrigo of HSR Filing Regarding Proposed Acquisition

 Mylan N.V. (NASDAQ: MYL) today announced that it has provided Perrigo Company plc (NYSE: PRGO; TASE) with notice of its filing today of the...

Apr 08, 2015, 11:29 ET

Mylan Proposes To Acquire Perrigo For $205 Per Share

Mylan N.V. (NASDAQ: MYL) today announced that Mylan has made a proposal to acquire Perrigo Company plc (NYSE: PRGO) in a...

Apr 07, 2015, 07:30 ET

Mylan Launches First Generic Version of Generess Fe®

 Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Norethindrone and Ethinyl Estradiol Tablets (Chewable) 0.8 mg/0.025 mg and Ferrous...

Mar 31, 2015, 19:47 ET
Mylan

Mylan N.V. Announces Pricing of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

 Mylan N.V. (NASDAQ: MYL) today announced the pricing of the underwritten public offering (the "Offering") of 35,000,000 ordinary shares held...

Mar 31, 2015, 09:48 ET

Mylan Launches Generic Exforge® Tablets

Mylan N.V. (NASDAQ: MYL) today announced the U.S. launch of Amlodipine and Valsartan Tablets, 5 mg/160 mg, 5 mg/320 mg, 10 mg/160 mg, 10 mg/320 mg,...

Mar 30, 2015, 06:30 ET
Mylan

Mylan N.V. Announces Commencement of Secondary Public Offering of a Portion of Abbott's Ordinary Shares

 Mylan N.V. (NASDAQ: MYL) today announced the underwritten public offering (the "Offering") of 35,000,000 ordinary shares held by certain...

Mar 12, 2015, 12:30 ET
Mylan

Mylan N.V. and Mylan Inc. Announce Successful Completion of Consent Solicitations for Mylan Inc.'s Notes

Mylan N.V. (NASDAQ: MYL) (the "Parent") and Mylan Inc. ("Mylan" and, together with the Parent, the "Companies") today announced the successful...

Mar 11, 2015, 07:30 ET

Mylan Launches Generic Subutex® Sublingual Tablets

 Mylan N.V. (NASDAQ: MYL) and Mylan Inc. today announced the U.S. launch of Buprenorphine Hydrochloride Sublingual Tablets, 2 mg and 8 mg,...

Mar 11, 2015, 07:00 ET

Mylan Launches Generic Antabuse® Tablets

Mylan N.V. (NASDAQ: MYL) and Mylan Inc. today announced the U.S. launch of Disulfiram Tablets USP, 250 mg and 500 mg, which is the generic version...

Mar 11, 2015, 06:30 ET

Mylan Launches First and Only Available Intermediate Dosage Strengths of Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr

 Mylan N.V. (Nasdaq: MYL) and Mylan Inc. today announced the U.S. launch of its Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr, adding...

Mar 06, 2015, 08:00 ET

Mylan to Present at the Barclays Global Healthcare Conference

 Mylan N.V. (Nasdaq: MYL) today announced that the Company will present at the Barclays Global Healthcare Conference on Wednesday, March 11,...

Mar 03, 2015, 08:55 ET
Mylan

Mylan N.V. and Mylan Inc. Announce Commencement of Consent Solicitations for Mylan Inc.'s Notes

Mylan N.V. (NASDAQ: MYL) (the "Parent") and Mylan Inc. ("Mylan" and, together with the Parent, the "Companies") today...

Mar 02, 2015, 17:06 ET
Mylan

Mylan Files Annual Report on Form 10-K for Year Ended Dec. 31, 2014

Mylan N.V. (Nasdaq: MYL) and Mylan Inc. today announced that Mylan Inc. filed its Annual Report on Form 10-K for the year ended December 31, 2014...

Mar 02, 2015, 16:11 ET

Mylan Fourth Quarter 2014 Adjusted Diluted EPS Increases 35% to $1.05 and Full Year Adjusted Diluted EPS Up 23% to $3.56

 Mylan N.V. (Nasdaq: MYL) and Mylan Inc. today announced Mylan Inc.'s financial results for the quarter and year ended December 31,...

Feb 27, 2015, 12:30 ET
Mylan

Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business

Mylan N.V. and Mylan Inc. (Nasdaq: MYL) today announced the successful completion of the acquisition of Abbott Laboratories' (NYSE: ABT) non-U.S....

Feb 23, 2015, 10:45 ET
Mylan

Mylan Specialty to Present Findings from EpiPen4Schools® Program Survey

 Mylan Specialty, the full integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ: MYL),...